DEF 14A Filing

Company

Enveric Biosciences, Inc.

Filed

May 20, 2016

Period of Report

May 2, 2016

Accession Number

0000921895-16-004629

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →